Report of Foreign Issuer (6-k)
June 04 2019 - 8:28AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the
month
of
June 2019
Commission File Number: 001-34541
GLOBAL CORD BLOOD CORPORATION
(Translation of registrants name into English)
48
th
Floor, Bank of China Tower
1 Garden Road
Central
Hong Kong S.A.R.
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F
o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
o
This report and the exhibit to this report are hereby incorporated by reference into the registration statements on Form F-3 (No. 333-183143 and No. 333-213730) of the Company.
On June 4, 2019, the Company issued a press release announcing its receipt of a non-binding proposal letter from Cordlife Group Limited. A copy of the press release is attached hereto as Exhibit 99.1.
Exhibits
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Press Release dated June 4, 2019
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
GLOBAL CORD BLOOD CORPORATION
|
|
|
|
|
By:
|
/s/ Albert Chen
|
|
Name:
|
Albert Chen
|
|
Title:
|
Chief Financial Officer
|
|
|
Dated:
June 4, 2019
|
|
3
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Sep 2023 to Sep 2024